Founding Principal of multi-billion-dollar family office backed, middle market private equity firm. High Bridge has been formed to proactively support a Clean Transition in Energy, Agriculture, and Industrial Infrastructure through the seamless integration of first world technology into those sectors, via the efforts of experienced investment professionals and seasoned operators with proven track records in their focus areas. Key sectors of focus include energy storage, grid-scale solutions, sodium-ion technologies, hydrogen technologies, next gen oil & gas, minerals & mining.

Jack Baumann is a corporate attorney with more than 30 years of experience in complex corporate transactional work, public and private securities offerings and mergers & acquisitions, joint ventures, investment advisory registration and all types of strategic business development initiatives. Experience includes extensive corporate transactional work at Skadden, Arps, Slate, Meagher & Flom LLP and Cogent Law Group, as well as KPMG and as Chief Legal Officer of Public Storage (NYSE:PSA), in addition to other public and private companies.• Lead counsel to Sacral Capital in connection with the creation of a $2 billion private equity/ venture capital fund, as well as state and Federal Registration as an Investment Advisor (2023)• Lead counsel to Poktpool, the premier staking pool for the token POKT in the Pocket network in connection with financings, corporate governance and securities work. (2023)• U.S. counsel to Eckert & Ziegler AG (Deutsche Börse: EZAG) in connection with U.S. securities law compliance and ESSOP design and implementation (2022).• Lead counsel to Sazmining Inc., a leading cryptocurrency mining and consulting firm, in connection with private securities offerings under Reg. D, merger and acquisition and general corporate activities, including its acquisition of and merger with GrayMatter Industries, LLC. (2021)• Represented Scimores Corporation in raising $50 million in connection with the development of The Floris Conservatory for Arts and Music, a state-of-the art academy for Arts and music, located in Fairfax County, Virginia. (2021)

• Responsible for business development, legal and government affairs functions for privately-held companies specializing in manufacture and distribution of diagnostic, therapeutic and outsourced nuclear medicine products and services. GMS presently has over 400 employees with operations in 7 countries throughout Asia & the Pacific Rim. Operations include nuclear pharmacies, positron emission tomography (PET) cyclotron sites, cold kit manufacturing plants in Australia and China, and radioisotope manufacturing centers in China and Taiwan.• Negotiated a strategic alliance with The Centre for Advanced Imaging (CAI) at The University of Queensland (UQ) in Brisbane, Australia (June 2014). This multi-million dollar alliance, along with the purchase/upgrade of an existing cyclotron in Brisbane (July 2014) are expected to greatly strengthen GMS’s position as the premier provider in the region of PET radiopharmaceuticals for the diagnosis of cancer, as well as brain and other disorders.• Negotiated expansions into Armenia, Vietnam and Myanmar (Burma). Armenian expansion includes long-term management, development and co-investment with the Republic of Armenia in the Armenian Center of Excellence in Oncology (ACEO), a regional center of excellence. Phase One of the ACEO is scheduled to open during the fourth calendar quarter of 2014.• Negotiated/developed key critical supplier relationships with Comecer, GE Healthcare, DraxImage, IBA, Mallinckrodt, Spectrum, Scintomics, IDB Holland and other major vendors (2012-2014).• Successfully led complex commercial litigations in the U.S. and Australia (July 2014).• Negotiated a variety of acquisitions, joint ventures, and material contracts and relationships for entities under common ownership, including majority-owned Point.360 (NASDAQ:PTSX).

• Responsible for Legal and Internal Audit Departments, including regulatory and government affairs functions of self-managed real estate investment trust or “REIT” that acquires, develops, owns and operates self-storage facilities for personal and business use. Public Storage is traded on the New York Stock Exchange and a member of the S&P 500 and the Forbes Global 2000. Public Storage is the largest owner and operator of self-storage facilities in the world. Also responsible for the same functions for affiliate PS Business Parks, Inc., an American Stock Exchange traded REIT and member of the S&P SmallCap 600, that has equity interests in approximately 19.6 million net rentable square feet of commercial space located in eight states.• Responsible for strategic and legal planning, negotiation and execution of Public Storage’s hostile acquisition of rival self-storage operator, Shurgard Storage Centers, Inc. This $5 billion transaction closed in August of 2006 and was the first hostile and first all-stock acquisition of a REIT. The merger increased the net rentable square footage of Public Storage’s self-storage facilities in the United States by approximately 36%, expanded Public Storage’s presence into seven European countries and increased Public Storage’s market capitalization by approximately $3 billion.• Responsible for revitalizing merger and acquisitions function, which resulted in the acquisition of over 100 additional self-storage properties at an approximate cost of approximately $750 million. These acquisitions more than doubled Public Storage’s annual revenues from $841 million to over $1.8 billion and increased the size of the self-storage portfolio by over 57%. This growth helped facilitate Public Storage’s addition to the S&P 500 index.• Responsible for strategic planning, structuring and negotiation of the March, 2008 sale for over $600 million of a 51% interest in Shurgard’s European portfolio to the New York Common Retirement Fund.

• Responsible for legal and government affairs functions of NASDAQ traded, international high technology health care services company, concentrating in the compounding and distribution of nuclear medicine pharmaceuticals and related products, medical imaging, niche manufacturing and radiotherapy. • Counsel to Board of Directors and executive management during the company's aggressive growth strategy and ensuing rapid increase in market capitalization from $160 million through its sale to Cardinal Health, Inc. for approximately $1 billion. • Negotiated, structured and provided strategic advice in connection with over 20 significant corporate acquisitions and related acquisitions and integrations of entities based on six continents. • Negotiated and established key strategic alliance with General Electric and a related acquisition and development program, which established the company as a major player in the manufacture and distribution of PET radiopharmaceuticals, thereby adding over $300 million to the company's market capitalization. • Designed and prosecuted a highly successful and cost effective litigation program which virtually eliminated "poaching" by competitors of exclusive service areas and which recovered over $7 million in damages. • Successfully defended the company in high-profile/risk patent litigation with DuPont Pharmaceuticals, and in $20 million breach of contract action with a major product supplier. • Led the design and administration of new stock option plans, first stock split, executive severance plans and takeover defenses.

• Responsible for corporate/transactional legal matters for U.S. member of international "Big 5" accounting, tax and consulting firm. • Negotiated, structured and provided advice in connection with a wide range of significant business initiatives; merger and acquisition transactions, major client engagements and the creation and restructuring of international branches and subsidiaries. • Represented KPMG in negotiations and frequent interaction with the staff from multiple branches of the U.S. Securities and Exchange Commission ("SEC") and other regulators in connection with KPMG's entry into the investment banking and turn around management businesses and in connection with matters of auditor independence. • Represented KPMG at regular roundtable discussions with representatives of other "Big 5" firms on issues of legal and professional practice.

• Corporate Counsel for major insurance holding company with respect to general corporate and merger and acquisition matters; securities law compliance/disclosure issues; and compensation and benefit plans. • General Counsel to Continental Asset Management Corp., an SEC-registered investment advisor with over $15 billion in assets under management, and had full responsibility for SEC and CFTC compliance; structuring and establishment of investment vehicles; legal oversight of debt and equity trading activity as well as real estate investment portfolio.

• Represented numerous Fortune 500 companies and other publicly and closely-held entities in the negotiation and structuring of a wide variety of corporate transactions, primarily in the mergers and acquisitions area, including public and private acquisitions and dispositions; leveraged buy-outs; proxy fights; hostile takeover defenses; recapitalizations; and stock repurchases.• Significant representations included successful defense of Caesars World, Inc. against simultaneous hostile tender offer and proxy fight. Strategies included attempted reincorporation/recapitalization of the company, as well as Dutch auction self-tender offer.